Related Experiment Videos
[Postoperative resistance against atracurium]
D Knüttgen1, M Doehn, D Zeidler
1Abteilung für Anästhesiologie, Kliniken der Stadt Köln, Krankenhaus Merheim.
Der Anaesthesist
|March 7, 1998
Summary
Postoperative resistance to atracurium can emerge, particularly in patients with septic complications following thoracic surgery. This resistance necessitates significant dose adjustments for effective neuromuscular blockade.
Area of Science:
- Anesthesiology
- Critical Care Medicine
- Pharmacology
Background:
- Neuromuscular blocking agents like atracurium are standard in anesthesia.
- Postoperative complications can influence drug efficacy.
- Understanding factors affecting neuromuscular blockade is crucial for patient safety.
Observation:
- Two case reports detail patients developing resistance to atracurium postoperatively.
- Both patients experienced septic complications after elective thoracic surgery.
- Significant changes in atracurium's potency and duration were observed.
Findings:
- Resistance manifested as prolonged onset, shortened duration, and increased maintenance doses of atracurium.
- One patient required a tripled maintenance dose, while another needed a significantly higher intubation dose.
- These changes occurred rapidly, suggesting a link to severe inflammatory responses.
Implications:
- Severe inflammatory reactions may induce rapid resistance to atracurium.
- Anesthesiologists must be vigilant for altered responses to neuromuscular blockers in septic patients.
- Further research is needed to elucidate the mechanisms behind this resistance.